MM, H., P, J., JD, W., SS, U., TZ, T., S, L., . . . AD, J. (2021). Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer. EMBO molecular medicine, 13(5), e13366. https://doi.org/10.15252/emmm.202013366
Chicago Style (17th ed.) CitationMM, Hoppe, et al. "Quantitative Imaging of RAD51 Expression as a Marker of Platinum Resistance in Ovarian Cancer." EMBO Molecular Medicine 13, no. 5 (2021): e13366. https://doi.org/10.15252/emmm.202013366.
MLA (9th ed.) CitationMM, Hoppe, et al. "Quantitative Imaging of RAD51 Expression as a Marker of Platinum Resistance in Ovarian Cancer." EMBO Molecular Medicine, vol. 13, no. 5, 2021, p. e13366, https://doi.org/10.15252/emmm.202013366.
Warning: These citations may not always be 100% accurate.